Collectively, the NeurAegis Leadership Team has...
Michel Baudry, Ph.D.
Founder & Chief Scientific Advisor
World-renowned neuroscientist, life science entrepreneur and professor. Co-Founder of 5 biotechnology companies across two countries. Identified calpain-2’s role in neurodegeneration and discovered novel calpain-2 protease inhibitors. Earned his Ph.D. (Biochemistry) from University Paris VII (Paris, France)
Stella M. Sung, Ph.D.
President & CEO
C-level (CEO/CBO) life Science/biotech executive with 25 years of experience in both operating and venture capital roles. Successful track record in negotiating, establishing, and executing transactions, agreements, and partnerships. Extensive experience in raising capital, building companies; served on or chaired Boards of >10 life science companies. Earned her Ph.D. (Chemistry) from Harvard University (National Science Foundation Pre-Doctoral Fellow).
Michael Palfreyman, Ph.D., D.Sc. Drug Development Advisor
Scientific leader in pharmaceutical industry for over 40 years. Internationally recognized leader in neuropharmacology and drug development and clinical Proof of Concept. Successfully led multiple IND filings and clinical programs. Holds a D.Sc. and a Ph.D. degree in Pharmacology, both from the University of Nottingham, UK.
Shujaath Mehdi, Ph.D.
Sanofi, Merrell Dow
Ph.D. from Yale University (biochemistry)
Philippe Bey, Ph.D.
ArQule, Sanofi Aventis, Hoechst Marion Roussel
Ph.D. from University Louis Pasteur (chemistry)
Kathy Fosnaugh, Ph.D.
Aminex Therapeutics, Sirna Therapeutics, Ligand Pharmaceuticals
Ph.D. from Cornell University (microbiology)
Scientific & Clinical Advisors
Ramon Diaz-Arrastia, M.D., Ph.D.
Presidential Professor of Neurology;
Director of Clinical Traumatic Brain Injury (TBI) Research
University of Pennsylvania,
Perelman School of Medicine
Greg Coulter, Ph.D.
University of Guelph, Canada
President, CTM Solutions, LLC
Pharmaceutical Development Specialist
Imad Najm, M.D.
Director, Epilepsy Center
Barry Jordan, M.D., M.P.H.
Chief Medical Officer
Rancho Los Amigos
National Rehabilitation Center
Independent Board Director & Advisor
Bernard Malfroy, Ph,D,
>40 Years in Drug Discovery & Development,
Directly Responsible for Designing Several Biopharmaceutical Products
Currently CEO, ViThera Pharmaceuticals and Board member of Eyegate Pharma and NeurAegis, Inc.
Joe Blanchard, M.B.A.
Co-Founder, President & CEO, Amorsa Therapeutics
Co-Founder, COO, CBO, Aushon Biosystems (acquired by Quanterix in 2018)
Other previous positions at Altus Pharmaceuticals, Genencor International, and Akzo Nobel